Welcome to Khiron
KHIRON Europe is a provider of high-quality, GMP-certified cannabinoid-based pharmaceutical products.
KHIRON is the trusted brand of choice for patients in Europe who want to improve their quality of life with exclusive high-quality pharmaceutical cannabis products.
Our goal is to meet the needs of patients with a sound scientific background and studies as well as carefully selected medicinal grade flowers and extracts.
of high-quality pharmaceutical products.
of continuing medical cannabis education programs for healthcare professionals.
We stand for...
Transparency
We stand for full transparency within our company and towards doctors, pharmacists and patients.
Learn more
Quality
We are constantly working on the further development of our high-quality (GMP-certified) cannabinoid-based pharmaceutical products.
Learn more
Reliability
Disruptions in product availability are to the expense of patients and prescribing doctors. We stand for reliability: a central value that determines our internal and external appearance.
Learn more
Integrity
We transfer our values lived in Latin America to Great Britain and use our clinical data from thousands of patients.
Learn more
Equality
We are consistently committed to equality - both inside and outside our company.
Learn more
Project Twenty21
Khiron is the first and only Latin-American provider in Project Twenty21 in the UK.
Project Twenty21 is the first and largest medical cannabis patient registry in Europe
Project Twenty21 aims to enroll 20.000 patients by the end of 2021, creating the largest body of evidence for the effectiveness and tolerability of medical cannabis.
Project Twenty21 is enrolling patients who have been diagnosed with one of the following conditions:
Chronic Pain, Anxiety Disorder, Multiple Sclerosis, Tourette Syndrome, Post-Traumatic Stress Disorder (PTSD), Substance use disorder (as a harm reduction strategy)
[rev_slider slidertitle=”Medicare Research1″ alias=”medicare-research1″]
What's new?
Our team of experts regularly informs you about
changes in the industry.
THE CBD-ILEMMA
A tale of two (cannabis) registries
Our partners
Our partners in UK
![CIC member[4733]](https://khironmed.co.uk/wp-content/uploads/2021/10/CIC-member4733-150x30.png "CIC member[4733]")